ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face

January 16, 1987

In Brief: New DRCCA Recruits: Cullen Will Be Greenwalds’s Deputy, Frelick To Become CCOP Project Officer

April 2, 1982

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

DRCCA Board Votes To End Support For CCPDS July 31, 1983

May 14, 1982

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982

Mass. Congressman Pressed For $1.5 M Proton Beam Funds

August 18, 1989